Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
5.13
0.00 (0.10%)
At close: May 20, 2025, 3:59 PM
5.16
0.49%
After-hours: May 20, 2025, 04:05 PM EDT
0.10% (1D)
| Bid | 5.02 |
| Market Cap | 44.32M |
| Revenue (ttm) | 142.13M |
| Net Income (ttm) | -62.52M |
| EPS (ttm) | -11.87 |
| PE Ratio (ttm) | -0.43 |
| Forward PE | -0.68 |
| Analyst | Buy |
| Ask | 5.5 |
| Volume | 37,563 |
| Avg. Volume (20D) | 135,100 |
| Open | 5.18 |
| Previous Close | 5.13 |
| Day's Range | 5.02 - 5.30 |
| 52-Week Range | 3.51 - 17.85 |
| Beta | 0.33 |
About KPTI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KPTI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KPTI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Karyopharm Therapeutics has released their quartely earnings
on May 12, 2025:
1 week ago
-20%
Karyopharm Therapeutics shares are trading lower a...
Unlock content with
Pro Subscription
6 months ago
+17.86%
Karyopharm Therapeutics shares are trading higher after the company announced that, following the FDA feedback, it will be replacing TSS50, one of the co-primary endpoints in the Phase 3 SENTRY Trial with Abs-TSS.
